SEARCH

SEARCH BY CITATION

References

  • Bhavsar AR, Ip MS & Glassman AR (2007): The risk of endophthalmitis following intravitreal triamcinolone injection in the DRCRnet and SCORE clinical trials. Am J Ophthalmol 144: 454456.
  • Borrillo JL, Sivalingam A, Martidis A & Federman JL (2003): Surgical ablation of retinal angiomatous proliferation. Arch Ophthalmol 121: 558561.
  • Boscia F, Furino C, Sborgia L, Reibaldi M & Sborgia C (2004): Photodynamic therapy for retinal angiomatous proliferations and pigment epithelium detachment. Am J Ophthalmol 138: 10771079.
  • Boscia F, Furino C, Prascina F, Delle Noci N, Sborgia L & Sborgia C (2005): Combined surgical ablation and intravitreal triamcinolone acetonide for retinal angiomatous proliferation. Eur J Ophthalmol 15: 513516.
  • Bottoni F, Massacesi A, Cigada M, Viola F, Musicco I & Staurenghi G (2005): Treatment of retinal angiomatous proliferation in age-related macular degeneration: a series of 104 cases of retinal angiomatous proliferation. Arch Ophthalmol 123: 16441650.
  • Bressler NM (2005): Retinal anastomosis to choroidal neovascularization: a bum rap for a difficult disease. Arch Ophthalmol 123: 17411743.
  • Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, Sy JP & Schneider S (2006): Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 355: 14321444.
  • Freund KB, Klais CM, Eandi CM, Ober MD, Goldberg DE, Sorenson JA & Yannuzzi LA (2006): Sequenced combined intravitreal triamcinolone and indocyanine green angiography-guided photodynamic therapy for retinal angiomatous proliferation. Arch Ophthalmol 124: 487492.
  • Freund KB, Ho IV, Barbazetto IA et al. (2008): Type 3 neovascularization: the expanded spectrum of retinal angiomatous proliferation. Retina 28: 201211.
  • Fung AE, Lalwani GA, Rosenfeld PJ et al. (2007): An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. Am J Ophthalmol 143: 566583.
  • Ghazi NG, Knape RM, Kirk TQ, Tiedeman JS & Conway BP (2008): Intravitreal bevacizumab (avastin) treatment of retinal angiomatous proliferation. Retina 28: 689695.
  • Gragoudas ES, Adamis AP, Cunningham ET Jr, Feinsod M & Guyer DR (2004): Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 351: 28052816.
  • Gross NE, Aizman A, Brucker A, Klancnik JM Jr & Yannuzzi LA (2005): Nature and risk of neovascularization in the fellow eye of patients with unilateral retinal angiomatous proliferation. Retina 25: 713718.
  • Joeres S, Heussen FM, Treziak T, Bopp S & Joussen AM (2007): Bevacizumab (Avastin) treatment in patients with retinal angiomatous proliferation. Graefes Arch Clin Exp Ophthalmol 245: 15971602.
  • Johnson TM & Glaser BM (2006): Focal laser ablation of retinal angiomatous proliferation. Retina 26: 765772.
  • Lai TY, Chan WM, Liu DT & Lam DS (2007): Ranibizumab for retinal angiomatous proliferation in neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 245: 18771880.
  • Meyerle CB, Freund KB, Iturralde D et al. (2007): Intravitreal bevacizumab (Avastin) for retinal angiomatous proliferation. Retina 27: 451457.
  • van de Moere A, Kak R, Sandhu SS & Talks SJ (2007): Anatomical and visual outcome of retinal angiomatous proliferation treated with photodynamic therapy and intravitreal triamcinolone. Am J Ophthalmol 143: 701704.
  • Nakata M, Yuzawa M, Kawamura A & Shimada H (2006): Combining surgical ablation of retinal inflow and outflow vessels with photodynamic therapy for retinal angiomatous proliferation. Am J Ophthalmol 141: 968970.
  • Panagiotidis D, Karagiannis DA & Baltatzis S (2006): Photodynamic therapy in retinal angiomatous proliferation stage I. Eur J Ophthalmol 16: 326329.
  • Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY & Kim RY (2006): Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355: 14191431.
  • Rouvas AA, Papakostas TD, Vavvas D, Vergados I, Moschos MM, Kotsolis A & Ladas ID (2009): Intravitreal ranibizumab, intravitreal ranibizumab with PDT, and intravitreal triamcinolone with PDT for the treatment of retinal angiomatous proliferation: a prospective study. Retina 29: 536544.
  • Saito M, Shiragami C, Shiraga F, Nagayama D & Iida T (2008): Combined intravitreal bevacizumab and photodynamic therapy for retinal angiomatous proliferation. Am J Ophthalmol 146: 935941. e1.
  • Sakimoto S, Gomi F, Sakaguchi H & Tano Y (2005): Recurrent retinal angiomatous proliferation after surgical ablation. Am J Ophthalmol 139: 917918.
  • Shiragami C, Iida T, Nagayama D, Baba T & Shiraga F (2007): Recurrence after surgical ablation for retinal angiomatous proliferation. Retina 27: 198203.
  • Silva RM, Cachulo ML, Figueira J, de Abreu JR & Cunha-Vaz JG (2007): Chorioretinal anastomosis and photodynamic therapy: a two-year follow-up study. Graefes Arch Clin Exp Ophthalmol 245: 11311139.
  • Slakter JS, Yannuzzi LA, Schneider U et al. (2000): Retinal choroidal anastomoses and occult choroidal neovascularization in age-related macular degeneration. Ophthalmology 107: 742753. discussion 753-4.
  • Spaide RF, Sorenson J & Maranan L (2003): Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization. Ophthalmology 110: 15171525.
  • Tobe T, Okamoto N, Vinores MA, Derevjanik NL, Vinores SA, Zack DJ & Campochiaro PA (1998): Evolution of neovascularization in mice with overexpression of vascular endothelial growth factor in photoreceptors. Invest Ophthalmol Vis Sci 39: 180188.
  • Wolf A, Kook D, Kreutzer T, Gandorfer A, Haritoglou C, Kampik A & Ulbig M (2008): [Anti-VEGF treatment for retinal angiomatous proliferation]. Ophthalmologe 105: 845851.
  • Yannuzzi LA, Negrao S, Iida T et al. (2001): Retinal angiomatous proliferation in age-related macular degeneration. Retina 21: 416434.